Objective To explore the causal relationship between Omega-3 fatty acids and the risk of breast cancer via Mendelian randomization analysis.Methods Analysis was conducted on data from genome-wide association studies(GWASs)on Omega-3 fatty acids and breast cancer.The selected instrumental variables(IVs)comprised genetic loci associated with Omega-3 fatty acids.Various Mendelian randomization analysis methods,including inverse-variance weighted(IVW)method,MR-Egger regression analysis,weighted median,simple models,and weighted models,were used to evaluate the causal relationship between Omega-3 fatty acids and the risk of breast cancer.Results A total of 47 single-nucleotide polymorphisms strongly associated with Omega-3 fatty acids were selected as IVs.The analysis methods,including IVW method,revealed no causal relationship between Omega-3 fatty acids and the risk of breast cancer(P>0.05).Analysis methods,such as MR-Egger regression analysis,did not detect significant gene-level pleiotropy(P=0.319),which indicates the high sensitivity and robustness of analysis results.Conclusion The findings of this study suggest the absence of a causal relationship between Omega-3 fatty acids and the risk of breast cancer.

Objective:To describe the clinical characteristics and diagnosis and treatment process of one patient with primary thyroid mucosa-associated lymphoid tissue(MALT)lymphoma,in order to broaden the diagnostic and therapeutic strategies for this disease. Methods:The clinical features,diagnosis and treatment of one patient with primary thyroid MALT lymphoma were reported,and the relevant literatures were reviewed. Results:The patient complained of"bilateral thyroid enlargement for over 3 months",and the preoperative thyroid B-ultrasound and neck CT examination showed significant enlargement of thyroid.The patient underwent thyroidectomy on the right lobe behind the sternum,and postoperative pathological diagnosis confirmed primary thyroid MALT lymphoma.After a definitive diagnosis,the radiotherapy was performed on the thyroid lesion and cervical lymph node drainage area at a dose of 30 Gy/15 sessions.There was no disease progression 7 months after radiotherapy. Conclusion:Primary thyroid MALT lymphoma is a subtype of primary thyroid lymphoma(PTL)that commonly occurs in elderly female patients(＞60 years)accompanied by Hashimotos's thyroiditis(HT),and presents progressive enlargement of neck masses or lymph nodes in a short period.The clinical diagnosis of PTL relies on pathological biopsy,and there are significant differences in the clinical manifestations,treatment approaches,and prognosis among different subtypes of PTL.

Breast cancer is the most common malignant tumor in women, and metastasis is the main cause of death in breast cancer patients. Circular RNA (circRNA) is prevalent, abundant in organisms, and are characterized by their stable structure, conserved sequences, and specific expression. CircRNA have emerged as crucial regulators in diverse human cancers including breast cancer. Increasing evidence suggests that circRNA are aberrantly expressed in tissues and cell lines of breast cancer and involved in breast cancer metastasis. However, systematic knowledge regarding circRNA involvement in metastatic breast cancer remains unclear. This review outline functional circRNA associated with breast cancer metastasis and discuss their underlying mechanisms, providing new ideas for early prediction, diagnosis and treatment of breast cancer metastasis in the future.

Breast cancer is the most common cancer among women worldwide, and it seriously threatens women′s life and health. circular RNA (circRNA) play a key role in the development and drug resistance of various cancers, including breast cancer. circRNA is an endogenous RNA molecule with a single-stranded closed structure, which has unique biological characteristics and function, and is a current research hotspot. This article will review circRNA as potential biomarkers to predict breast cancer drug resistance and therapeutic targets.

Objective:To investigate the clinicopathological features, treatment and prognosis of neuroendocrine carcinoma of the breast.Methods:Clinical data of 26 patients with neuroendocrine carcinoma of the breast admitted to the Northern Jiangsu People's Hospital from July 2013 to Mar 2021 were analyzed.Results:All 26 cases were female, the average aged of (62.81±11.95) years, the first clinical manifestations were painless breast masses, the average size being of (23.34±9.47) mm. At the time of diagnosis, regional lymph node metastasis was found in 4 cases, 1 case developed distant metastasis. Most patients' were on stage Ⅱ by TNM staging, molecular typing was Luminal A, and invasive mammary carcinoma with neuroendocrine differentiation was most common, with positive rates of ER and PR of 96%, the positive rate of CgA and Syn were 69% and 100%, and there was not positive expression of HER2. All patients received surgical treatment, 25 patients underwent postoperative adjuvant therapy. Twenty-five patients were followed up for a median follow-up time of 39.50 months. During the follow-up, 3 cases developed distant metastasis, 1 case died, the mean survival time was (40.81±26.90) months, there was ao satistically significant difference compared with invasive mammary carcinoma ( t=1.291, P=0.209). The mean disease free interval is (39.96±27.58) months. The overall survival and disease free survival at 1, 2 and 5 years are 100%, 100% and 87%, respectively. Conclusions:Neuroendocrine carcinoma of the breast occurs more frequently in elderly women, often with large tumor size, low rate of regional lymph node and distant metastasis, moderate histological grade, early clinical stage, and the molecular typing is mostly Luminal A.The overall prognosis is fair.

Breast cancer as one of the common malignant tumors in women, has received widespread attention. Aerobic glycolysis is the main metabolic pathway of breast cancer cells, and its key enzymes play an important role in the metabolism of cancer cells. The key enzymes of glycolysis are regulated by the Wnt/β-catenin signaling pathway. Abnormal activation of the Wnt/β-catenin signaling pathway regulates downstream target genes, thereby affecting the activities of key glycolysis enzymes. Glycolysis and Wnt/β-catenin signaling pathway play an important role in the occurrence and development of breast cancer, but the specific regulatory relationship between the two has not been studied in depth. Therefore, this article summarizes the regulation relationship between aerobic glycolysis and Wnt/β-catenin pathway in order to explore new strategies for breast cancer treatment.

Invasion and metastasis are the leading causes of death from breast cancer. Epithelial-mesenchymal transition (EMT) can induce cancer metastasis by promoting tumor malignances and reprogramming tumor metabolism. As an important part of glucose metabolism, aerobic glycolysis not only provides sufficient energy for rapid growth of tumor cells, but also provides metastasis advantage for tumor cells by promoting the EMT process. In addition, the crosstalk network between glycolysis and EMT synergistically triggers cancer metastasis. Therefore, abnormal glucose metabolism and EMT play a key role in the occurrence and development of breast cancer metastasis, suggesting its clinical promise for the management of breast cancer metastasis.

Solid papillary carcinoma of the breast is a rare malignant tumor with neuroendocrine characteristics.This paper reports the diagnosis and treatment of a male patient with solid papilla carcinoma.Combined with the previous literature,the clinical manifestations,pathology,diagnosis,differential diagnosis and treatment prognosis are discussed,which provides a reference for clinicians.

Endocrine therapy is one of the standard treatment options for breast cancer which plays an important role in treating patients with estrogen receptor (ER) positive and human epidermal growth factor receptor 2 (HER2) negative breast cancer.However,some patients develop resistance during therapy due to factors such as tumor heterogeneity,which is particularly acute in the treatment of advanced breast cancer.Based on aiming at a rational and effective treatment,some clinical trials recently have demonstrated that compared to endocrine therapy alone,cyclin-dependent kinase 4/6 (CDK4/6) inhibitors combined with endocrine therapy can significantly improve the prognosis of ER-positive,HER2-negative advanced breast cancer.Its main products are Palbociclib,Ribociclib and Abemaciclib.This review mainly focuses on the mechanism and related clinical trials of CDK4/6 inhibitor inhibitors in ER-positive,HER2-negative advanced breast cancer.

Breast cancer is one of the most common malignant tumors in clinic,and its pathogenesis has been extensively studied by people.miRNA play an important regulatory role in normal breast cell proliferation and apoptosis,they are widely involved in the occurrence and development of breast cancer and are attracting more and more attention as new tumor markers.The Wnt/β-catenin signaling pathways involved in breast cancer and other malignancies have long been confirmed.Recent studies have shown that a variety of important members of the Wnt/β-catenin signaling pathway can be regulated as miRNA target genes,affecting the occurrence and development of breast cancer.At the same time,Wnt/β-catenin signaling pathway changes can also cause the expression of related miRNA changes.Both miRNA and Wnt/ β-catenin signaling pathways play an important regulatory role in the pathogenesis of breast cancer,but the complex regulatory relationship between them has not been elucidated yet.Therefore,in this review,the roles of miRNA and Wnt/β-catenin signaling in breast cancer and its relationship with each other are reviewed in order to gain a deeper understanding of the complex pathogenesis of breast cancer and to explore new diagnostic molecular markers and therapeutic targets for breast cancer,provide a new idea for the diagnosis and treatment of breast cancer.